Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-18
SponsorUniversidad Nacional Andres Bello

About this trial

This randomized controlled trial will compare the effects of neuroplastic and functional changes of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) when presented in two periods (2HG; n=24) versus a single period (1HG; n=24) in people with bilateral CP. The 1HG will receive 65 hours of HABIT-ILE over one intervention period; the 2HG will receive 130 hours over two intervention periods, within 6 months apart. Children will be assessed at 6 time points: baseline, three weeks after the start, at 3, 6, 7 and 9 months after the start of the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children with medical diagnosis of bilateral cerebral palsy

Cognitive capacity and language that allows understanding and following the therapist's instructions.

Manual Ability Classification System (MACS) levels I to III

Bimanual Fine Motor Function (BFMF) levels I to III

Disqualifiers

Severe visual problems

Movement restriction due to orthopedic surgery in less than a year

Treatment with botulinum toxin and/or baclofen pump in the last 6 months

Contraindications to receive transcranial magnetic stimulation (epileptic history, metallic implants, neoplasm, etc.)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hand-Arm Bimanual Intensive Therapy Including Lower Extremities

    Behavioral

    Structured bimanual tasks training, with gradual increase in motor difficulty, requiring increased postural adjustments and the use of the lower extremities.

  • Hand-Arm Bimanual Intensive Therapy Including Lower Extremities

    Behavioral

    Structured bimanual tasks training, with gradual increase in motor difficulty, requiring increased postural adjustments and the use of the lower extremities.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Double periodExperimental treatment 1 intervention
Group B: Single periodExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Changes in Gross Motor Function

The Gross Motor Function Measure is a standardized observational instrument designed to measure changes in gross motor function over time or following an intervention in children and youth with cerebral palsy using Rasch analysis. It is scored on a scale of 0 to 3, where 0 means the person cannot perform the activity and 3 means the person can complete the item. The score is converted to a percentage. A higher percentage means a better gross motor function.

Time frame
Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)

Secondary outcomes

1

Both Hands Assessment (BoHA)

The Both Hands Assessment is a valid test for children with mild to moderate bilateral manual abilities impairments. It can evaluate bimanual activity performance and the level of upper extremity asymmetry. It rates performance between 1 (does not do) and 4 (effective). The final score is converted to BoHA units (logit 0 - 100), where higher scores reflect better bimanual use.

Time frame
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)]
2

Melbourne 2 Assessment (MA2)

The Melbourne 2 Assessment (MA2) assesses the unilateral performance of the upper extremities, quantifying the dexterity, fluency, accuracy, and range of movement during several tasks of reaching and manipulation. The result is obtained as a percentage of the function of each item. A higher percentage means a better unilateral performance of the upper extremity.

Time frame
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)]
3

Test of Arm Selective Control (TASC)

The TASC test assesses the selective voluntary motor control of upper limbs in individuals with cerebral palsy. The participant must execute eight movements in the upper extremity. The execution of each sequence will be assessed on a scale of 0, 1, or 2, from absence, impairment, or normality of voluntary selective motor control, respectively, with a maximum of 16 points per side and 32 points overall.

Time frame
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)
4

Selective Control Assessment of the Lower Extremity (SCALE)

The SCALE test assesses the selective voluntary motor control of lower limbs in individuals with cerebral palsy. The participant must execute five movements in the lower extremity. The execution of each sequence will be assessed on a scale of 0, 1 or 2, from absence, impairment, or normality of voluntary selective motor control respectively, with a maximum of 10 points per side and 20 points overall.

Time frame
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.